Table 5 Univariate analyses of factors associated with incisional SSI following total gastrectomy

Sex

 Men

15

42

0.403

 Women

3

15

Age (years)

71.2 ± 9.4

70.6 ± 10.2

0.98

ASA

 I

1

12

0.318

 II

14

37

 III

3

8

BMI (≥25/<25 kg/m²)

8/10

8/49

0.006

4.9 (1.49–16.15)

0.009

VFA (≥100/<100 cm²)

12/6

14/43

0.001

6.14 (1.94–19.41)

0.002

SFA (cm²) (mean ± SD)

136.9 ± 73.3

102.5 ± 59.5

0.104

Diabetes mellitus

3

11

0.803

Cardiac history

5

8

0.144

Pulmonary history

1

3

0.921

Chronic kidney disease

2

2

0.186

Pathologic Stage

 I

6

19

0.527

 II

4

12

 III

8

20

 IV

0

6

Neoadjuvant chemotherapy

1

2

0.699

Residual gastrectomy

0

6

0.151

Splenectomy

3

15

0.403

Resection of pancreatic tail

1

2

0.699

Partial resection of colon

1

1

0.383

Number of retrieved lymph nodes (mean ± SD)

39.7 ± 18.2

43.9 ± 23.5

0.85

Operating time (min) (mean ± SD)

225.1 ± 64.2

208.6 ± 69.6

0.278

Blood loss (ml) (mean ± SD)

368.2 ± 369.9

377.4 ± 517.7

0.985